Proteomic Discovery of Biomarkers to Predict Prognosis of High-Grade Serous Ovarian Carcinoma

Proteomic Discovery of Biomarkers to Predict Prognosis of High-Grade Serous Ovarian Carcinoma

Initial identification of biomarkers predicting the exact prognosis of high-grade serous ovarian carcinoma (HGSOC) is important in precision cancer medicine. This study aimed to investigate prognostic biomarkers of HGSOC through proteomic analysis. We conducted label-free liquid chromatography-mass...

Full description

Bibliographic Details
Main Authors:	Se Ik Kim, Minsun Jung, Kisoon Dan, Sungyoung Lee, Cheol Lee, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song, Dohyun Han, Maria Lee
Format:	Article
Language:	English
Published:	MDPI AG 2020-03-01
Series:	Cancers
Subjects:	ovarian neoplasms high-grade serous carcinoma proteomics immunohistochemistry prognosis
Online Access:	https://www.mdpi.com/2072-6694/12/4/790

Similar Items

Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer
by: Se Ik Kim, et al.
Published: (2019-05-01)

Impact of CT-Determined Sarcopenia and Body Composition on Survival Outcome in Patients with Advanced-Stage High-Grade Serous Ovarian Carcinoma
by: Se Ik Kim, et al.
Published: (2020-02-01)

Classification of High-Grade Serous Ovarian Carcinoma by Epithelial-to-Mesenchymal Transition Signature and Homologous Recombination Repair Genes
by: Min-Hwan Sohn, et al.
Published: (2021-07-01)

Proteome profiling of low grade serous ovarian cancer
by: Haniyeh Bashi zadeh fakhar, et al.
Published: (2019-07-01)

Histologic and molecular analysis of patient derived xenografts of high-grade serous ovarian carcinoma
by: Ruifen Dong, et al.
Published: (2016-09-01)

Low-grade serous carcinoma with extensive osseous metaplasia arising from ovarian serous cystadenofibroma
by: Renan Ribeiro e Ribeiro, et al.
Published: (2021-05-01)

Proteomic Analysis of Pre-Invasive Serous Lesions of the Endometrium and Fallopian Tube Reveals Their Metastatic Potential
by: Mitchell Acland, et al.
Published: (2020-12-01)

Development of Machine Learning Models to Predict Platinum Sensitivity of High-Grade Serous Ovarian Carcinoma
by: Suhyun Hwangbo, et al.
Published: (2021-04-01)

The poor prognosis of sarcomatoid carcinoma arising from low grade serous ovarian cancer: A case report and review of the literature
by: Paulina Haight, et al.
Published: (2021-05-01)

An unusual occurrence of synchronous gastrointestinal stromal tumor and high-grade serous carcinoma of the endometrium - A rare combination
by: Daphne Fonseca, et al.
Published: (2020-01-01)

High-grade versus low-grade serous carcinoma of the ovary – current differential diagnosis and perspectives
by: Manuela POPA, et al.
Published: (2018-12-01)

HtrA1 expression and the prognosis of high-grade serous ovarian carcinoma: a cohort study using digital analysis
by: Andréanne Gagné, et al.
Published: (2018-08-01)

Digital pathology-based study of cell- and tissue-level morphologic features in serous borderline ovarian tumor and high-grade serous ovarian cancer
by: Jun Jiang, et al.
Published: (2021-01-01)

Cell Origins of High-Grade Serous Ovarian Cancer
by: Jaeyeon Kim, et al.
Published: (2018-11-01)

Clinical Stratification of High-Grade Ovarian Serous Carcinoma Using a Panel of Six Biomarkers
by: Swapnil C. Kamble, et al.
Published: (2019-03-01)

Bilateral synchronous high-grade serous carcinoma and clear cell carcinoma in right and left ovaries with immunohistochemical confirmation: An exceptional finding
by: Agarwal Preeti, et al.
Published: (2014-01-01)

CT features of low grade serous carcinoma of the ovary
by: Harpreet K. Pannu
Published: (2015-01-01)

The association between expression of p53 and aggressiveness of serous adenocarcinoma of the uterine cervix
by: Sul Lee, et al.
Published: (2020-01-01)

Can TP53 variant negative be high-grade serous ovarian carcinoma? A case series
by: Lawrence Kasherman, et al.
Published: (2021-05-01)

Management of the Elderly Patients with High-Grade Serous Ovarian Cancer in the REAL-WORLD Setting
by: Michalis Liontos, et al.
Published: (2021-03-01)

Integrated Proteomic and Glycoproteomic Characterization of Human High-Grade Serous Ovarian Carcinoma
by: Yingwei Hu, et al.
Published: (2020-10-01)

Primary peritoneal serous adenocarcinoma mimicking carcinoma ovary with omental metastasis
by: Jaydeep N Pol, et al.
Published: (2017-01-01)

Outcomes of non-high grade serous carcinoma after neoadjuvant chemotherapy for advanced-stage ovarian cancer: a Korean gynecologic oncology group study (OV 1708)
by: Young Shin Chung, et al.
Published: (2019-04-01)

IMP3 as a cytoplasmic biomarker for early serous tubal carcinogenesis
by: Wang, Yiying, et al.
Published: (2014)

Cytology positive pericardial effusion causing tamponade in patients with high grade serous carcinoma of the ovary
by: Joni Kooy, et al.
Published: (2020-08-01)

Serous versus high-grade endometrioid endometrial carcinoma: immunohistochemistry of RFP is not useful for differentiation
by: Cigdem Ussakli, et al.
Published: (2016-11-01)

Space-and Time-Resolved Metabolomics of a High-Grade Serous Ovarian Cancer Mouse Model
by: Botros, A., et al.
Published: (2022)

<i>USP19</i> and <i>RPL23</i> as Candidate Prognostic Markers for Advanced-Stage High-Grade Serous Ovarian Carcinoma
by: Haeyoun Kang, et al.
Published: (2021-08-01)

Immunohistochemical distinction between mesothelial and adenocarcinoma cells in serous effusions: A combination panel-based approach with a brief review of the literature
by: Murugan Paari, et al.
Published: (2009-04-01)

IMMUNOHISTROCHEMISTRY AND FLOW CYTOMETRIC CHARACTERISTICS OF INTRATUMORAL LYMPHOCYTES IN OVARIAN SEROUS ADENOCARCINOMA
by: E. V. Zuyeva, et al.
Published: (2014-09-01)

KRAS/BRAF Analysis in Ovarian Low-Grade Serous Carcinoma Having Synchronous All Pathological Precursor Regions
by: Kohei Nakamura, et al.
Published: (2016-04-01)

STING pathway expression in low‐grade serous carcinoma of the ovary: an unexpected therapeutic opportunity?
by: Jutta Huvila, et al.
Published: (2021-11-01)

Durable response to hormonal therapy in a patient with rapidly progressive low-grade serous ovarian cancer: A case report
by: Catherine H. Watson, et al.
Published: (2020-08-01)

Abdominopelvic Metastasis of Endometrial Serous Carcinoma Initially Misdiagnosed as Early-Stage Low-Grade Endometrioid Carcinoma: The Importance of Recognizing Minimal Uterine Serous Carcinoma
by: Jiheun Han, et al.
Published: (2020-12-01)

EGFR and HER2 Expression in Primary Ovarian High-Grade Serous Carcinoma and Their Prognostic Value
by: Mayada S. Farrag, et al.
Published: (2021-06-01)

Late recurrence of pStage 1 low-grade serous ovarian tumor presenting as a symptomatic bone metastasis: a case report
by: Chiaki Kubo, et al.
Published: (2018-06-01)

Mineralocorticoid receptor antagonists in chronic central serous chorioretinopathy
by: Ana Sanhueza, et al.
Published: (2020-09-01)

Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer
by: Joung, J.-G, et al.
Published: (2022)

Central Serous Chorioretinopathy: Pathogenesis and Management
by: Semeraro F, et al.
Published: (2019-12-01)

CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer—A Multicenter Analysis
by: Berchuck, A., et al.
Published: (2022)